Ngā hua rapu - Victoria Wood

  • E whakaatu ana i te 1 - 8 hua o te 8
Whakamahine hua
  1. 1
    HDAC inhibitor-based therapies and haematological malignancy

    HDAC inhibitor-based therapies and haematological malignancy mā Lindsay Stimson, Victoria Wood, Omar Khan, Susan Fotheringham, N B La Thangue

    I whakaputaina 2009
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  2. 2
    ‘Therapeutic landscapes’ and the importance of nostalgia, solastalgia, salvage and abandonment for psychiatric hospital design

    ‘Therapeutic landscapes’ and the importance of nostalgia, solastalgia, salvage and abandonment for psychiatric hospital design mā Victoria Wood, Wil Gesler, Sarah Curtis, Ian Spencer, Helen Close, James Mason, Joe Reilly

    I whakaputaina 2015
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  3. 3
    Developmentally appropriate healthcare for young people: a scoping study

    Developmentally appropriate healthcare for young people: a scoping study mā Albert Farré, Victoria Wood, Tim Rapley, Jeremy Parr, Debbie Reape, J. E. R. McDonagh

    I whakaputaina 2014
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  4. 4
    Health professionals’ and managers’ definitions of developmentally appropriate healthcare for young people: conceptual dimensions and embedded controversies

    Health professionals’ and managers’ definitions of developmentally appropriate healthcare for young people: conceptual dimensions and embedded controversies mā Albert Farré, Victoria Wood, J. E. R. McDonagh, Jeremy Parr, Debbie Reape, Tim Rapley

    I whakaputaina 2016
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  5. 5
    Genome-wide Loss-of-Function Screen Reveals an Important Role for the Proteasome in HDAC Inhibitor-Induced Apoptosis

    Genome-wide Loss-of-Function Screen Reveals an Important Role for the Proteasome in HDAC Inhibitor-Induced Apoptosis mā Susan Fotheringham, Mirjam T. Epping, Lindsay Stimson, Omar Khan, Victoria Wood, Francesco Pezzella, René Bernards, Nicholas B. La Thangue

    I whakaputaina 2009
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  6. 6
    HR23B is a biomarker for tumor sensitivity to HDAC inhibitor-based therapy

    HR23B is a biomarker for tumor sensitivity to HDAC inhibitor-based therapy mā Omar Khan, Susan Fotheringham, Victoria Wood, Lindsay Stimson, Chunlei Zhang, Francesco Pezzella, Madeleine Duvic, David Kerr, Nicholas B. La Thangue

    I whakaputaina 2010
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  7. 7
    Epstein–Barr virus-encoded EBNA1 modulates the AP-1 transcription factor pathway in nasopharyngeal carcinoma cells and enhances angiogenesis in vitro

    Epstein–Barr virus-encoded EBNA1 modulates the AP-1 transcription factor pathway in nasopharyngeal carcinoma cells and enhances angiogenesis in vitro mā John D. O’Neil, Thomas J. Owen, Victoria Wood, Kathryn Date, Robert Valentine, Marilyn B. Chukwuma, John R. Arrand, William O. Dawson, Lawrence S. Young

    I whakaputaina 2008
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  8. 8
    The utility of patient specific induced pluripotent stem cells for the modelling of Autistic Spectrum Disorders

    The utility of patient specific induced pluripotent stem cells for the modelling of Autistic Spectrum Disorders mā Graham Cocks, Sarah Curran, Priya Gami‐Patel, Dafe Uwanogho, Aaron R. Jeffries, Annie Kathuria, Walter Lucchesi, Victoria Wood, Rosemary Dixon, Caroline Mackie Ogilvie, Thomas Steckler, Jack Price

    I whakaputaina 2013
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:

Ngā utauta rapu: